US5955331A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Recombinant retroviruses with amphotropic and ecotropic host ranges
Assignee: Whitehead Institute for Biomedical Research
•
Filing: 1995-06-07
•
Granted: 1999-09-21
•
Expires: 2015-06-07
Abstract
Abstract Packaging cell lines useful for the generation of helper-free recombinant retroviruses with amphotropic or ecotropic host ranges, methods of constructing such packaging cell lines and methods of using the recombinant retroviruses to introduce DNA of interest into eukaryotic cells, both in vitro and in vivo.
Inventors
- 👤 Olivier Danos
- 👤 Richard C. Mulligan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 15:27
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/86; C07; C07K; C07K14/00; C07K14/005; C12N7/00; C12N2740/00; C12N2740/00011; C12N2740/10011; C12N2740/13011; C12N2740/13022; C12N2740/13041; C12N2740/13043; C12N2740/13045; C12N2740/13051; C12N2740/13052
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
91 words
A stable retroviral packaging cell line which generates helper-free recombinant retrovirus with an amphotropic host range, said stable retroviral packaging cell line comprising packaging cells, wherein the retrovirally derived component of said packaging cells' genome comprises stably incorporated first and second replication-defective retroviral constructs, wherein said first and second replication-defective retroviral constructs: 1) encode and express mutually exclusive regions of the gag, pol, and env genes; 2) were separately and sequentially introduced into the genome of said packaging cells; and wherein the incorporated env gene is derived from an amphotropic virus.
Claim 2
Dependent Claim
91 words
A stable retroviral packaging cell line which generates helper-free recombinant retrovirus with an amphotropic host range, said stable retroviral packaging cell line comprising packaging cells, wherein the retrovirally derived component of said packaging cells' genome comprises stably incorporated first and second replication-defective retroviral constructs, wherein said first and second replication-defective retroviral constructs: 1) encode and express mutually exclusive regions of the gag, pol, and env genes; 2) were separately and sequentially introduced into the genome of said packaging cells; and wherein the incorporated env gene is derived from an amphotropic virus.
Claim 3
Dependent Claim
121 words
A stable retroviral packaging cell line according to claim 1 wherein: a) the genome of the first replication-defective retroviral construct comprises: 1) a defective Psi packaging region; 2) a functional form of at least one of the group consisting of gag and pol; 3) a defective env region; and b) the genome of the second replication-defective retroviral construct comprises: 1) a defective Psi packaging region; 2) a functional amphotropic env gene; and 3) defective gag and/or pol regions which corresponds to the gag and/or pol regions which are not defective in the first retroviral construct, wherein said sequential introduction into the genome of said packaging cells results in the expression of complete but physically separated gag, pol and env coding regions.
Claim 4
Dependent Claim
39 words
A packaging cell line according to claim 2 wherein said first and second replication-defective retroviral constructs additionally comprise 3' LTR sequences, and wherein there is a deletion in the 3' LTR sequence of said first or second retroviral construct.
Claim 5
Dependent Claim
39 words
A packaging cell line according to claim 2 wherein said first and second replication-defective retroviral constructs additionally comprise 3' LTR sequences, and wherein there are deletions in the 3' LTR sequences of said first and second replication-defective retroviral constructs.
Claim 6
Dependent Claim
19 words
A packaging cell line according to claim 3 or 4 wherein said deletions remove the entire 3' LTR sequence.
Claim 7
Dependent Claim
18 words
A packaging cell line according to claim 3 or 4 wherein the first replication-defective retroviral construct is pCRIPenv.
Claim 8
Dependent Claim
18 words
A packaging cell line according to claim 3 or 4 wherein the second replication-defective retroviral construct is pCRIPAMgag.
Claim 9
Independent Claim
30 words
A method of using the packaging cell line according to any one of claims 1, 2, 3, or 4, comprising the step of producing amphotropic retrovirus in said cell line.
Claim 10
Dependent Claim
22 words
A method of using the packaging cell line of claim 5 comprising the step of producing amphotropic retrovirus in said cell line.
Claim 11
Dependent Claim
22 words
A method of using the packaging cell line of claim 6 comprising the step of producing amphotropic retrovirus in said cell line.
Claim 12
Dependent Claim
22 words
A method of using the packaging cell line of claim 7 comprising the step of producing amphotropic retrovirus in said cell line.
Claim 13
Independent Claim
197 words
A method of making a stable retroviral packaging cell line which generates helper-free recombinant retrovirus with an amphotropic host range, comprising the steps of: a) transfecting mammalian host cells with a first replication-defective retroviral construct, the genome of which comprises: i) sequences derived from the 5' and 3' LTRs of a first retrovirus of interest; (ii) a defective Psi packaging region; (iii) a functional form of at least one region selected from the group consisting of gag and pol; (iv) a defective env region; and (v) a eucaryotic promoter for expressing the functional retroviral genes; b) culturing the transfected cells of step a); c) transfecting the cells cultured in step b) with a second replication-defective retroviral construct, the genome of which comprises: (i) sequences derived from the 5' and 3' LTRs of a second retrovirus of interest; (ii) a defective Psi packaging region; (iii) a functional amphotropic env gene; (iv) defective gag and/or pol regions which corresponds to the gag and/or pol regions which are not defective in the first retroviral construct; and d) culturing the cells transfected in step c) whereby a packaging cell comprising complete but physically separated gag/pol and env coding regions is produced.
Claim 14
Independent Claim
197 words
A method of making a stable retroviral packaging cell line which generates helper-free recombinant retrovirus with an amphotropic host range, comprising the steps of: a) transfecting mammalian host cells with a first replication-defective retroviral construct, the genome of which comprises: i) sequences derived from the 5' and 3' LTRs of a first retrovirus of interest; (ii) a defective Psi packaging region; (iii) a functional form of at least one region selected from the group consisting of gag and pol; (iv) a defective env region; and (v) a eucaryotic promoter for expressing the functional retroviral genes; b) culturing the transfected cells of step a); c) transfecting the cells cultured in step b) with a second replication-defective retroviral construct, the genome of which comprises: (i) sequences derived from the 5' and 3' LTRs of a second retrovirus of interest; (ii) a defective Psi packaging region; (iii) a functional amphotropic env gene; (iv) defective gag and/or pol regions which corresponds to the gag and/or pol regions which are not defective in the first retroviral construct; and d) culturing the cells transfected in step c) whereby a packaging cell comprising complete but physically separated gag/pol and env coding regions is produced.
Claim 15
Dependent Claim
38 words
A method according to claim 12 wherein said first and second replication-defective retroviral constructs additionally comprise 3' LTR sequences, and wherein there is a deletion in the 3' LTR sequence of said first or second replication-defective retroviral constructs.
Claim 16
Dependent Claim
37 words
A method according to claim 12 wherein said fist and second replication-defective retroviral constructs additionally comprise 3' LTR sequences, and wherein there are deletions in the 3' LTR sequences of said first and second replication-defective retroviral constructs.
Claim 17
Dependent Claim
17 words
A method according to claim 12 or 14 wherein said deletions remove the entire 3' LTR sequence.
Claim 18
Dependent Claim
16 words
A method according to claim 13 or 14 wherein the first replication-defective retroviral construct is pCRIPenv.
Claim 19
Dependent Claim
16 words
A method according to claim 13 or 14 wherein the second replication-defective retroviral construct is pCRIPAMgag.
References Cited (Backward Citations)
US4650764A
Cited
DE3636287A1
Cited
WO1989007136A2
Cited
US5278056A
Cited
WO1990002806A1
Cited
US5449614A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-09-20 | 2003-03-22 | 2003-09-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-09-20 | 2007-03-22 | 2007-09-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-09-20 | 2011-03-22 | 2011-09-21 | $7700.00 | Window Closed / Lapsed |